ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	16/210	79/7206	6.52153026505e-10
ko04510	Focal adhesion	25/210	240/7206	2.35631868208e-08
ko05131	Shigellosis	13/210	82/7206	5.71253595203e-07
ko04974	Protein digestion and absorption	14/210	96/7206	5.99494580228e-07
ko04810	Regulation of actin cytoskeleton	22/210	264/7206	7.65337097712e-06
ko04668	TNF signaling pathway	14/210	120/7206	9.04015704816e-06
ko04666	Fc gamma R-mediated phagocytosis	14/210	122/7206	1.09688101585e-05
ko05205	Proteoglycans in cancer	22/210	271/7206	1.16388727002e-05
ko05146	Amoebiasis	12/210	99/7206	2.72034294135e-05
ko05410	Hypertrophic cardiomyopathy (HCM)	12/210	100/7206	3.01313556897e-05
ko04657	IL-17 signaling pathway	11/210	87/7206	3.97546032228e-05
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	10/210	79/7206	8.87318985316e-05
ko00643	Styrene degradation	3/210	4/7206	9.55265373103e-05
ko05132	Salmonella infection	11/210	98/7206	0.000120151601585
ko05100	Bacterial invasion of epithelial cells	11/210	99/7206	0.000131770123109
ko04060	Cytokine-cytokine receptor interaction	15/210	191/7206	0.000433062914026
ko04611	Platelet activation	13/210	163/7206	0.000902874246471
ko05133	Pertussis	9/210	87/7206	0.000913510946588
ko00512	Mucin type O-glycan biosynthesis	5/210	29/7206	0.00134448714121
ko04670	Leukocyte transendothelial migration	12/210	151/7206	0.00146055263991
ko05130	Pathogenic Escherichia coli infection	8/210	77/7206	0.0017037277413
ko04380	Osteoclast differentiation	11/210	134/7206	0.00176566181428
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/210	135/7206	0.0018741989514
ko04210	Apoptosis	13/210	180/7206	0.00222718062517
ko04215	Apoptosis - multiple species	6/210	47/7206	0.00225809409265
ko04151	PI3K-Akt signaling pathway	22/210	390/7206	0.00275863133946
ko04912	GnRH signaling pathway	10/210	122/7206	0.002863269685
ko04530	Tight junction	15/210	228/7206	0.00367428971225
ko05222	Small cell lung cancer	8/210	89/7206	0.00424790130653
ko05160	Hepatitis C	11/210	153/7206	0.004953570533
ko05414	Dilated cardiomyopathy	9/210	112/7206	0.00523718374223
ko05134	Legionellosis	7/210	74/7206	0.00556121426271
ko04064	NF-kappa B signaling pathway	8/210	96/7206	0.00670970643237
ko05200	Pathways in cancer	25/210	492/7206	0.00753897598551
ko05164	Influenza A	11/210	167/7206	0.00941009844822
ko05145	Toxoplasmosis	9/210	126/7206	0.0110809121079
ko05219	Bladder cancer	5/210	48/7206	0.0124053246883
ko04144	Endocytosis	18/210	342/7206	0.012883033425
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/210	92/7206	0.0174839168234
ko05418	Fluid shear stress and atherosclerosis	11/210	173/7206	0.0177043034754
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/210	182/7206	0.0213885639813
ko04022	cGMP-PKG signaling pathway	1/210	216/7206	0.0219874782718
ko04370	VEGF signaling pathway	6/210	77/7206	0.0243258560307
ko01522	Endocrine resistance	8/210	124/7206	0.0280349907303
ko04068	FoxO signaling pathway	10/210	167/7206	0.0305584289266
ko04640	Hematopoietic cell lineage	5/210	64/7206	0.0381216847086
ko05210	Colorectal cancer	6/210	86/7206	0.0389950325915
ko04015	Rap1 signaling pathway	14/210	278/7206	0.0428769309448
ko04662	B cell receptor signaling pathway	6/210	88/7206	0.0428805101643
ko04621	NOD-like receptor signaling pathway	9/210	157/7206	0.0487341597218